下载 Nurse’s Drug Handbook App - v3.5.24

请下载并共享Nurse’s Drug Handbook App - v3.5.24，它是类别医疗中的特色应用之一。
另外，还有一些其他应用可以作为X-RAY WOW, Jan Aushadhi Sugam (BPPI), Inject App, Patchwork, NYP, Medical Dictionary Free & Offline - Diseases下载。如果您对Nurse’s Drug Handbook App - v3.5.24感到满意。

Nurse’s Drug Handbook App - v3.5.24发布，Nurse’s Drug Handbook App - v3.5.24是当今最好的免费和最佳手机应用程序之一。位于应用商店的医疗类别中。

Nurse’s Drug Handbook App - v3.5.24的最低操作系统为Android 5.0+及更高版本。因此，如果尚未升级手机，则必须更新。

在APKDroid上，您将免费下载Nurse’s Drug Handbook App - v3.5.24 APK，最新版本为3.5.24，发布日期为2021-08-06，文件大小为10.2 MB。根据Google Play商店的统计数据，大约有1000次下载。您可以根据需要更新在Android上单独下载或安装的应用。还可以更新您的应用。您可以使用最新功能并提高安全性和应用程序的稳定性。现在就享受它

The most up-to-date, practical, and easy-to-use nursing drug reference. Updated annually, it provides accurate and timely facts on hundreds of drugs from A-Z.

DESCRIPTION
The Jones & Bartlett Learning 2020 Nurse’s Drug Handbook is the most up-to-date, practical, and easy-to-use nursing drug reference. Updated annually, it provides accurate and timely facts on hundreds of drugs from A-Z. Written in a no-nonsense style that speaks your language in terms you use every day, it offers concise and consistently formatted drug entries organized alphabetically.

The 2020 Nurse is Drug Handbook,

Key Features:

- Index of all generic, trade, and alternate drug names
- Chemical and therapeutic classes, FDA pregnancy risk category, and controlled substance schedule
- Indications and dosages, as well as route, onset, peak, and duration information
- Incompatibilities and contraindications
- Interactions with drugs, food, and activities
- Adverse reactions
- Nursing considerations, including key teaching points for patients
- Mechanism-of-action illustrations
- Warnings and precautions
- Updated antineoplastic drug therapy appendix
- Addition of bolded Life-Threatening Adverse Reactions (ADRs)

NEW TO THIS EDITION
New drugs added to the 2020 Nurse's Drug Handbook include: PEGlated-auci jivi, baloxavir marboxil, baricitinib, inactivated-zhzo, didanosine, doravirine, Eravacycline, erenumab-aooe, fremanezumab-vfrm, frovatriptan, galcanezumab-gnlm, ganiciclovir, ibalizumab-uiyk, lofexidine, lubiprostone, omadacycline, plazomicin, revefenacin, rifamycin, saquinavir, sarecycline, semaglutide, sodium zirconium cyclosilicate, sufentanil, tildrakizumab-asmn

UI/UX & Performance Enhancements